Home › Mild Cognitive Impairment › Connecticut
Mild Cognitive Impairment clinical trials in Connecticut
9 studies for Mild Cognitive Impairment are looking for participants at sites in Connecticut.
Cities in Connecticut
A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
- Ki Health Partners, LLc, dba New England Institute for Clinical Research, Stamford
RecruitingPhase 2
Ages 55 to 85 · All sexes · Updated Sep 22, 2026 · NCT07589595Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
- Yale University, New Haven
RecruitingPhase 3
Ages 50 to 90 · All sexes · Updated Sep 21, 2026 · NCT07177352Music for Pain and Dementia
- Connecticut Mental Health Clinic, New Haven
Recruiting
Ages 50 to 80 · All sexes · Updated Sep 21, 2026 · NCT07602283Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older Adults
- Yale University, New Haven
- VA Connecticut Healthcare System, West Haven
RecruitingPhase 4Healthy volunteers welcome
Ages 75 and older · All sexes · Updated Sep 1, 2026 · NCT04262206The Mito-Frail Trial: Effects of MitoQ on Vasodilation, Mobility and Cognitive Performance in Frail Older Adults
- UConn Health, Farmington
RecruitingPhase 2Healthy volunteers welcome
Ages 65 to 80 · All sexes · Updated Aug 12, 2026 · NCT06027554Neurologic Stem Cell Treatment Study
- MD Stem Cells, Westport
Recruiting
Ages 18 and older · All sexes · Updated Jun 26, 2026 · NCT02795052Optimizing Evidence-based HIV Prevention Targeting People Who Inject Drugs on PrEP
- APT Foundation, New Haven
RecruitingPhase 4
Ages 18 and older · All sexes · Updated Jun 15, 2026 · NCT05669534Cognitive Remediation
- UConn Health, Farmington
Recruiting
Ages 60 and older · All sexes · Updated Feb 24, 2026 · NCT07171450MitoQ for Early-phase Schizophrenia-spectrum Disorder and Mitochondrial Dysfunction
- Yale School of Medicine, New Haven
RecruitingPhase 2/3
Ages 18 to 35 · All sexes · Updated Sep 25, 2025 · NCT06191965From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.